Achieve Life Sciences, Inc.'s latest moves, explained simply — so you know why the numbers change.
Straight from SEC filings · updated 6 Aug 2026Shows company leadership was reelected and charter changes were approved by shareholders, affecting how the company operates.
New board members bring fresh perspectives and expertise; each receives $40,000 annual retainer and stock options worth monitoring.
Allows company to raise money by selling stock or other securities later without filing new paperwork each time.
Quarterly earnings report shows how much money company earned or lost in first three months of year.
New board member came from major investor Frazier Life Sciences, giving them influence over company decisions.
Company sold shares and warrants to investors for cash; investors can buy more shares at $3.51 later if FDA approves smoking drug.
Annual report shows company's total revenue, expenses, and financial health for entire previous year.
Stocky reads Achieve Life Sciences, Inc.'s official filings with the U.S. Securities and Exchange Commission (SEC) — the 8-K, 10-Q and 10-K reports every public company must file — and summarizes each one in plain English, with a link back to the original document.
Achieve Life Sciences, Inc.'s most recent tracked filing was a 8-K on 6 Jul 2026: Nine directors elected; amended charter approved July 2026.
No. These event summaries are educational — generated from public SEC filings to help beginners understand what a company is doing. They are not buy or sell recommendations.
Educational, not financial advice. Company events summarized from public SEC filings.
Data as of 6 Aug 2026.